Drug Spending Expected To Rise By $200 Bil. In 2022 Compared To Pre-ACA Levels
This article was originally published in RPM Report
Executive Summary
Implementation of the Affordable Care Act in 2014 will help significantly increase growth for pharma. The increase won’t be as big as it might have been, thanks to the Supreme Court ruling allowing states to opt out of Medicaid expansion, but it should still be a significant acceleration.